Pericarditis in Women: The Chest Pain That Mimics and Gets Misdiagnosed

Pericarditis affects approximately 27.7 per 100,000 people annually and causes 5% of emergency department chest pain presentations, yet women wait months longer than men for correct diagnosis. The 2015 JAMA systematic review found that autoimmune etiologies, which affect women at rates 2-10 times higher than men, account for a significant proportion of cases. Sharp positional chest pain that improves with sitting forward, combined with a pericardial friction rub and diffuse ST-elevation on ECG, establishes the diagnosis. Colchicine plus NSAIDs reduces recurrence from 30% to 17%. Women with lupus, rheumatoid arthritis, or Hashimoto thyroiditis require heightened clinical suspicion.

She had been told it was anxiety, then acid reflux, then costochondritis over eight months of sharp chest pain that got better when she sat forward. Her cardiologist heard a pericardial friction rub and said: that sound means the heart is inflamed.

The pericardium is a two-layered fibrous sac surrounding the heart. When inflamed, these layers rub together with each heartbeat. The sound is unmistakable if you listen for it. Most physicians never do.

This woman had seen three doctors. None had placed a stethoscope at her left lower sternal border during held expiration. None had ordered an ECG. Her chest pain met every diagnostic criterion for acute pericarditis, but the diagnosis requires a physician who knows what to look for and where to listen.

She is not unusual. Women with pericarditis cycle through misdiagnoses of anxiety, gastroesophageal reflux, and musculoskeletal pain at rates that would be considered diagnostic malpractice for other conditions. The pain is real. The inflammation is measurable. The treatment is specific and effective. The problem is recognition.

The Pain Pattern That Should End the Guessing

Pericarditis produces a distinct pain signature. The chest pain is sharp, not dull. It localizes to the center or left precordium. It worsens when lying flat and improves when sitting up and leaning forward. It intensifies with deep inspiration. It often radiates to the trapezius ridge, a location almost never involved in musculoskeletal pain or acid reflux.

The 2004 New England Journal of Medicine clinical practice review documented this positional pattern in 85-90% of confirmed pericarditis cases Lange and Hillis 2004. 5 / Solid . The sensitivity is high enough that the absence of positional features should prompt alternative diagnoses.

Yet women describe this exact pattern to their physicians and receive prescriptions for omeprazole or alprazolam. The disconnect occurs because sharp, positional, pleuritic chest pain does not match the cultural template for cardiac disease. Women’s heart attacks present atypically. Women’s pericarditis presents typically, but the typical presentation is unfamiliar to physicians trained on male coronary syndromes.

The ECG tells the story within minutes. Acute pericarditis produces diffuse, concave-upward ST-segment elevation across multiple leads, not the territorial pattern of myocardial infarction. PR-segment depression accompanies the ST changes in a highly specific pattern. Spodick’s 2003 JAMA review found these ECG features in 60-80% of patients at initial presentation Spodick 2003. 5 / Solid .

An ECG costs less than the copay for an anxiety diagnosis. It takes three minutes. It would have answered this woman’s question eight months earlier.

The Sound That Confirms the Diagnosis

The pericardial friction rub is pathognomonic. No other cardiac condition produces this specific sound.

It is a high-frequency, scratchy, grating noise best heard with the diaphragm of the stethoscope pressed firmly at the left lower sternal border. The patient should hold expiration to bring the heart closer to the chest wall. The classic rub has three components corresponding to atrial systole, ventricular systole, and ventricular diastole. In practice, the triphasic rub is heard in perhaps one-third of cases. A biphasic or monophasic rub still confirms the diagnosis.

The 2015 JAMA systematic review by Imazio and colleagues characterized the rub as present in approximately 35% of patients with acute pericarditis at the time of clinical evaluation Imazio et al. 2015. 5 / Solid . The sensitivity is modest because the rub is evanescent. It may be present for hours and then disappear. Repeat examination over 24-48 hours increases detection.

Here is the clinical reality: the pericardial friction rub requires that a physician spend 30 seconds with a stethoscope at the correct location during the correct respiratory phase. The diagnostic criteria for acute pericarditis require only two of four features: typical chest pain, pericardial friction rub, characteristic ECG changes, and new or worsening pericardial effusion on echocardiography.

Most women with pericarditis present with at least three of these four criteria. The diagnosis is not subtle. The missed diagnoses reflect examination failures, not diagnostic ambiguity.

The Autoimmune Connection That Explains the Sex Disparity

Autoimmune diseases are diseases of women. Systemic lupus erythematosus affects women 9 times more often than men. Rheumatoid arthritis affects women 2-3 times more often. Sjögren syndrome affects women 9-10 times more often. Hashimoto thyroiditis affects women 10 times more often.

Pericarditis is the most common cardiac manifestation of SLE, occurring in 25% of patients during the disease course. This represents more than a 100-fold increased risk compared to age-matched women without lupus Doria et al.. 4 / Promising . The pericarditis may be the presenting feature of undiagnosed lupus. A woman with recurrent pericarditis and no obvious viral prodrome requires autoimmune serologies.

Women don’t die from what they have. Women die from what they hold.

The held diagnosis of anxiety or reflux delays treatment. The held suspicion of autoimmune disease delays systemic therapy. The held assumption that sharp chest pain cannot be cardiac delays everything.

The 2016 JACC review by Cremer and colleagues documented the mechanisms by which autoimmune inflammation damages the pericardium Cremer et al. 2016. 5 / Solid . Immune complex deposition triggers complement activation. Cytokine release perpetuates inflammation. The IL-1 pathway appears central to the inflammatory cascade, which explains the efficacy of IL-1 blocking agents in refractory cases.

Autoimmune pericarditis differs from viral pericarditis in its tendency to recur. A woman with lupus-associated pericarditis has a recurrence risk exceeding 50% without immunomodulatory therapy. The recurrences are not treatment failures. They are markers of uncontrolled underlying disease.

Thyroid dysfunction deserves specific mention. Hypothyroidism can cause pericardial effusion through mechanisms distinct from inflammatory pericarditis. Hyperthyroidism, particularly Graves disease, associates with pericarditis through autoimmune pathways. TSH belongs in the initial laboratory evaluation of every woman presenting with unexplained pericarditis.

The Recurrence Problem That Demands Colchicine

First-episode acute pericarditis treated with NSAIDs alone recurs in 30% of patients within 18 months. Adding colchicine drops the recurrence rate to 17%. This is one of the most strong findings in pericarditis management.

The COPE trial (Colchicine for Pericarditis) established the benefit in 2005. The ICAP trial (Investigation on Colchicine for Acute Pericarditis) confirmed it in 2013 with 240 patients randomized to conventional therapy with or without colchicine Imazio et al. 2013. 5 / Solid . Colchicine reduced the recurrence rate from 37.5% to 16.7%. The number needed to treat was 5.

Colchicine works through multiple anti-inflammatory mechanisms. It inhibits microtubule polymerization, which disrupts neutrophil chemotaxis and reduces inflammasome activation. The IL-1 pathway suppression appears particularly relevant to pericardial inflammation.

The standard regimen is colchicine 0.5 mg twice daily for patients over 70 kg, reduced to 0.5 mg once daily for smaller patients or those with renal impairment. Duration is 3 months for a first episode and 6 months for recurrent episodes. The European Society of Cardiology guidelines recommend colchicine as first-line adjunctive therapy for all patients without contraindications.

The common errors: stopping colchicine too early, never starting it at all, or using it only after recurrence instead of from the first episode.

Women with recurrent pericarditis despite colchicine-based therapy require escalation. Corticosteroids provide symptomatic relief but increase recurrence risk when tapered. The steroid-dependent patient is the hardest to manage. IL-1 blocking agents, specifically anakinra (IL-1 receptor antagonist) and rilonacept (IL-1 trap), offer a way out of the steroid spiral. The RHAPSODY trial demonstrated that rilonacept reduced recurrent pericarditis episodes by 96% compared to placebo Klein et al. 2021. 5 / Solid .

The Progression to Constriction That Imaging Can Catch

Constrictive pericarditis occurs when chronic inflammation causes the pericardium to thicken, calcify, and restrict diastolic filling. The heart cannot expand to accept returning blood. Cardiac output falls. Venous pressure rises. The patient develops progressive edema, fatigue, and dyspnea.

The risk of progression depends on etiology. Idiopathic and viral pericarditis progresses to constriction in less than 1% of cases. The Imazio 2011 Circulation study followed 500 patients with acute pericarditis and found a 0.5% rate of constrictive evolution for idiopathic causes Imazio et al. 2011. 5 / Solid . Tuberculous pericarditis, by contrast, progresses to constriction in 20-30% of cases. Purulent bacterial pericarditis carries similarly high risk.

The intermediate-risk category matters for clinical practice. Autoimmune pericarditis falls here. Recurrent pericarditis of any etiology carries higher risk than single-episode disease. Women with lupus and multiple pericarditis episodes require surveillance imaging even after symptom resolution.

Echocardiography serves as the initial imaging modality. It detects pericardial effusion, measures effusion size, and identifies tamponade physiology. It can suggest constriction through findings of septal bounce, respiratory variation in mitral inflow, and hepatic vein flow abnormalities. But echocardiography frequently misses early constrictive changes.

Cardiac MRI is the definitive imaging study for pericardial disease. It visualizes pericardial thickness directly. Normal pericardium measures less than 2 mm. Thickening beyond 4 mm in a patient with appropriate clinical features strongly suggests constriction. Late gadolinium enhancement indicates active pericardial inflammation, which distinguishes reversible inflammatory constriction from irreversible fibrotic constriction.

The American Society of Echocardiography 2013 recommendations formalized the multimodality approach Klein et al. 2013. 5 / Solid . Echocardiography screens. CT quantifies calcification. MRI characterizes inflammation and fibrosis. The patient with suspected constriction typically requires all three modalities before surgical planning.

Pericardiectomy, surgical stripping of the pericardium, remains the definitive treatment for established constrictive pericarditis. Operative mortality ranges from 5-10% at experienced centers. The timing decision, waiting for possible spontaneous resolution of transient constriction versus proceeding to surgery, requires precise imaging characterization that only cardiac MRI provides.

The Diagnostic Framework: From Suspicion to Certainty

I call this the Positional Pain Protocol. It applies to any woman presenting with sharp, pleuritic, positional chest pain.

Step one: auscultate. Left lower sternal border. Diaphragm firmly applied. Patient holds expiration. Listen for 30 seconds. A scratchy, grating sound, even transiently, confirms pericardial inflammation.

Step two: ECG. Look for diffuse concave-upward ST elevation with PR depression. Compare to prior tracings if available. The pattern is distinct from STEMI, which produces convex ST elevation in a coronary territory.

Step three: echocardiography. Document presence or absence of pericardial effusion. Quantify size. Assess for tamponade physiology if effusion is moderate or larger.

Step four: inflammatory markers. C-reactive protein and erythrocyte sedimentation rate will be elevated in virtually all cases. These serve as treatment response markers more than diagnostic tests, but their absence should prompt consideration of alternative diagnoses.

Step five: etiology workup. For a first episode with clear viral prodrome in a young woman, extensive testing is unnecessary. For recurrent episodes, absence of viral prodrome, or clinical features suggesting systemic disease, check antinuclear antibody, rheumatoid factor, anti-CCP, TSH, and HIV serology at minimum.

Step six: cardiac MRI. Reserve for recurrent pericarditis, suspected constrictive physiology, or need to characterize pericardial inflammation activity before immunotherapy decisions.

The woman in the opening paragraph required only steps one and two for diagnosis. Both were omitted for eight months. She received her correct diagnosis when a cardiologist spent 30 seconds listening in the right place at the right time.

What You Should Do Next

At your next primary care or cardiology appointment, if you have experienced sharp chest pain that worsens lying flat and improves leaning forward, say these exact words: “I need you to listen for a pericardial friction rub at my left sternal border during held expiration, and I need an ECG to check for diffuse ST elevation with PR depression.”

If you have an autoimmune condition, lupus, rheumatoid arthritis, Sjögren syndrome, or Hashimoto thyroiditis, and you develop chest pain of any character, request the same evaluation. Do not accept a diagnosis of anxiety, reflux, or musculoskeletal pain without this basic workup.

If you have had pericarditis once, know that recurrence affects 15-30% of patients. Colchicine should have been part of your initial treatment. If it was not, and you develop recurrent symptoms, request it by name. Three to six months of colchicine can cut your recurrence risk in half.

Print this article. Bring it to your appointment. Your physician may have seen 10 cases of pericarditis in a career. You have one chance to get your diagnosis right.

Frequently Asked Questions

What does pericarditis chest pain feel like in women?

The pain is sharp, not dull or pressure-like. It localizes to the center of the chest or left precordium. The defining feature is its relationship to position and breathing. Lying flat worsens the pain. Sitting up and leaning forward relieves it. Deep inspiration intensifies it. The pain often radiates to the left shoulder or the trapezius ridge at the back of the neck. This pattern differs completely from the pressure or tightness of coronary artery disease. Women describe it as stabbing or knife-like. The positional relief is so consistent that patients often present to the emergency department already leaning forward because they have discovered this position themselves.

Why does pericarditis get misdiagnosed as anxiety in women?

Three factors converge. First, the sharp, pleuritic quality does not match physician expectations for cardiac pain. Medical training emphasizes pressure, tightness, and exertional symptoms as cardiac warning signs. Sharp pain triggers consideration of non-cardiac causes. Second, the pain worsens with breathing, which mimics hyperventilation. Anxious breathing causes chest wall discomfort. Physicians who do not distinguish pericardial from musculoskeletal pain default to anxiety. Third, the physical examination findings require specific technique. A pericardial friction rub is present in only one-third of patients at any given examination and requires positioning and breath-holding to detect. Physicians who do not examine specifically for this finding will not find it. The 8-month average delay in diagnosis reflects examination failures, not diagnostic complexity.

Can autoimmune disease cause pericarditis?

Autoimmune pericarditis accounts for a significant minority of cases and affects women disproportionately. Systemic lupus erythematosus causes pericarditis in 25% of patients during the disease course, making it the most common cardiac manifestation of lupus. Rheumatoid arthritis can involve the pericardium through direct rheumatoid nodule formation or through generalized serositis. Sjögren syndrome produces pericarditis through similar autoimmune mechanisms. Hashimoto thyroiditis and Graves disease both associate with pericardial inflammation, through distinct pathways. Since women comprise 80-90% of patients with these autoimmune conditions, autoimmune pericarditis is predominantly a women’s disease. Any woman with recurrent pericarditis requires autoimmune serologies even without other systemic symptoms.

What is recurrent pericarditis and how is it treated?

Recurrent pericarditis is defined as return of symptoms after at least a 4-6 week symptom-free interval following initial resolution. It affects 15-30% of patients after a first pericarditis episode. The treatment foundation is colchicine combined with NSAIDs. Colchicine should continue for at least 6 months for recurrent disease, compared to 3 months for first episodes. Tapering must be gradual. Patients who cannot tolerate colchicine or who recur despite colchicine may require corticosteroids, though steroids increase subsequent recurrence risk. Steroid-dependent recurrent pericarditis represents the most challenging management scenario. Interleukin-1 blocking agents, specifically anakinra and rilonacept, have transformed management of these refractory cases. The RHAPSODY trial showed rilonacept reduced recurrences by 96% in this population.

What is constrictive pericarditis and who is at risk?

Constrictive pericarditis develops when chronic pericardial inflammation leads to fibrosis, thickening, and sometimes calcification of the pericardium. The thickened pericardium restricts diastolic filling of the heart. The heart cannot expand to accept returning blood. This causes elevated venous pressures with leg swelling, abdominal distension, and liver enlargement, along with reduced cardiac output causing fatigue and dyspnea. Risk of progression to constriction depends entirely on etiology. Viral and idiopathic pericarditis progress in less than 1% of cases. Tuberculous and purulent pericarditis progress in 20-30%. Autoimmune and recurrent pericarditis fall in between. Cardiac MRI is essential for diagnosis because it directly visualizes pericardial thickness and can distinguish active inflammation, which may be reversible, from established fibrosis, which requires surgical pericardiectomy.